Understanding Drug-eluting Resorbable Scaffold
A Guide to Drug-eluting Resorbable Scaffold
What is Drug-eluting Resorbable Scaffold?
Defining Drug-eluting Resorbable Scaffold
Esprit™ BTK Everolimus Eluting Resorbable Scaffold System
Esprit is designed to physically support the vessel and release everolimus to reduce the risk of re-narrowing.
Over three years, the scaffold is resorbed to allow vessel remodeling and reduce the chances of late complications.
The FDA approved the device because the resorbable scaffold has a lower rate of vessel re-narrowing than balloon angioplasty in chronic limb-threatening ischemia (CLTI).
The information and opinions presented here are based on the experience, training, and interpretation of the author. Although the information has been researched and reviewed for accuracy, e4health does not accept any responsibility or liability regarding errors, omission, misuse, or misinterpretation. This information is intended as a guide; it should not be considered a legal/consulting opinion or advice.